| http://www.w3.org/ns/prov#value | - It provides innovative products and therapies for use by medical professionals to meet the healthcare needs of their patients.Mannkind Corp. (NASDAQ:MNKD): Thomson David (VP & General Counsel) sold 10,000 shares at a price of $5.80.MannKind Corporation is a biopharmaceutical company, which is focused on the discovery, development and commercialization of therapeutic products for diseases such as d
|
